Sistema de Información Esencial en Terapéutica y Salud


Última actualización: 18/9/2020
SIETES contiene 93096 citas

 1 a 20 de 35 siguiente >>
Presentar resultados
Seleccionar todas
1.Tiene citas relacionadas Cita con resumen
Dong M, Mürdter TE, Klotz U. Telomeres and telomerase as novel drug targets: reflections on the 2009 Nobel Prize i Physiology or Medicine. Eur J Clin Pharmacol 2010;66:1-30. [Ref.ID 87653]
2.Tiene citas relacionadas Cita con resumen
Klotz U. Impact of CYP2C19 polymorphisms on the clinical action of proton pump inhibitors (PPIs). Eur J Clin Pharmacol 2009;65:1-2. [Ref.ID 85035]
3.Enlace a cita original
Shi S, Klotz U. Proton pump inhibitors: an update of their clinical use and pharmacokinetics. Eur J Clin Pharmacol 2008;64:935-51. [Ref.ID 84296]
4. Cita con resumen
Klotz U. Drug-related risks. Eur J Clin Pharmacol 2007;63:983-4. [Ref.ID 81426]
5. Cita con resumen
Klotz U. The bridging function of clinical pharmacology. Eur J Clin Pharmacol 2007;63:817-9. [Ref.ID 80973]
Dilger K, Herrlinger C, Peters J, Seyberth HW, Schweer H, Klotz U. Effects of celecoxib and diclofenac on blood pressure, renal function, and vasoactive prostanoids in young and elderly subjects. J Clin Pharmacol 2002;42:985-94. [Ref.ID 63369]
9. Cita con resumen
Treiber G, Wittig J, Ammon S, Walker S, van Doorn LJ, Klotz U. Clinical outcome and influencing factors of a new short-term quadruple therapy for Helicobacter pylori eradication. Arch Intern Med 2002;162:153-60. [Ref.ID 60296]
Schwab M, Klotz U. Pharmacokinetic considerations in the treatment of inflammatory bowel disease. Clin Pharmacokinet 2001;40:723-51. [Ref.ID 59303]
12. Cita con resumen
Klotz U. Pharmacokinetic considerations in the eradication of Helicobacter pylori. Clin Pharmacokinet 2000;38:243-70. [Ref.ID 49675]
Schwab M, Röder F, Mörike K, Thon KP, Klotz U. Drug-induced hyponatraemia in elderly patients. Br J Clin Pharmacol 1999;48:105-6. [Ref.ID 45218]
14.Tiene citas relacionadas
Schwab M, Röder F, Mörike K, Thon KP, Klotz U. Prevention of falls in elderly people. Lancet 1999;353:928. [Ref.ID 43554]
Li G, Gong PL, Qiu J, Zeng FD, Klotz U. Stereoselective steady state disposition and action of propafenone in Chinese subjects. Br J Clin Pharmacol 1998;46:441-5. [Ref.ID 41061]
Klotz U, Ammon E. Clinical and toxicological consequences of the inductive potential of ethanol. Eur J Clin Pharmacol 1998;54:7-12. [Ref.ID 37828]
17.Tiene citas relacionadas
Klotz U, Raimann I. Effect of cimetidine on the clearance of benzodiazepines. N Engl J Med 1980;303:754. [Ref.ID 35657]
18. Cita con resumen
Gugler R, Hartmann M, Rudi J, Brod I, Huber R, Steinijans VW, Bliesath H, Wurst W, Klotz U. Lack of pharmacokinetic interaction of pantoprazole with diazepam in man. Br J Clin Pharmacol 1996;42:249-52. [Ref.ID 28639]
Walter-Sack I, Klotz U. Influence of diet and nutritional status on drug metabolism. Clin Pharmacokinet 1996;31:47-64. [Ref.ID 28447]
Klotz U, Szefler SJ, Guest editors. Zileuton: a pharmacokinetic profile. Clin Pharmacokinet 1995;29:1-124. [Ref.ID 25353]
Seleccionar todas
 1 a 20 de 35 siguiente >>